
Peptide And Oligonucleotide CDMO Global Market Report 2025
Description
Peptide And Oligonucleotide CDMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on peptide and oligonucleotide cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for peptide and oligonucleotide cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide and oligonucleotide cdmo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Product: Peptides; Oligonucleotides
2) By Service Type: Contract Development; Contract Manufacturing;
3) By Application: Therapeutics; Research Applications; Diagnostics; Other Applications
4) By End User: Biopharmaceutical Companies; Pharmaceutical Companies; Research Institutes; Academic and Government Organizations; Others End Users
Subsegments:
1) By Peptides: Active Pharmaceutical Ingredients (Apis); Peptide Drug Products; Peptide Synthesis And Manufacturing Services
2) By Oligonucleotides: Antisense Oligonucleotides; Sirna And Mrna Oligonucleotides; Oligonucleotide Synthesis And Manufacturing Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Ajinomoto Co. Inc.; Lonza Group Ag; Wuxi Apptec Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on peptide and oligonucleotide cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for peptide and oligonucleotide cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptide and oligonucleotide cdmo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Product: Peptides; Oligonucleotides
2) By Service Type: Contract Development; Contract Manufacturing;
3) By Application: Therapeutics; Research Applications; Diagnostics; Other Applications
4) By End User: Biopharmaceutical Companies; Pharmaceutical Companies; Research Institutes; Academic and Government Organizations; Others End Users
Subsegments:
1) By Peptides: Active Pharmaceutical Ingredients (Apis); Peptide Drug Products; Peptide Synthesis And Manufacturing Services
2) By Oligonucleotides: Antisense Oligonucleotides; Sirna And Mrna Oligonucleotides; Oligonucleotide Synthesis And Manufacturing Services
Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Ajinomoto Co. Inc.; Lonza Group Ag; Wuxi Apptec Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Peptide And Oligonucleotide CDMO Market Characteristics
- 3. Peptide And Oligonucleotide CDMO Market Trends And Strategies
- 4. Peptide And Oligonucleotide CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Peptide And Oligonucleotide CDMO Growth Analysis And Strategic Analysis Framework
- 5.1. Global Peptide And Oligonucleotide CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Peptide And Oligonucleotide CDMO Market Growth Rate Analysis
- 5.4. Global Peptide And Oligonucleotide CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Peptide And Oligonucleotide CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Peptide And Oligonucleotide CDMO Total Addressable Market (TAM)
- 6. Peptide And Oligonucleotide CDMO Market Segmentation
- 6.1. Global Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peptides
- Oligonucleotides
- 6.2. Global Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contract Development
- Contract Manufacturing
- 6.3. Global Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Therapeutics
- Research Applications
- Diagnostics
- Other Applications
- 6.4. Global Peptide And Oligonucleotide CDMO Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biopharmaceutical Companies
- Pharmaceutical Companies
- Research Institutes
- Academic and Government Organizations
- Others End Users
- 6.5. Global Peptide And Oligonucleotide CDMO Market, Sub-Segmentation Of Peptides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Active Pharmaceutical Ingredients (Apis)
- Peptide Drug Products
- Peptide Synthesis And Manufacturing Services
- 6.6. Global Peptide And Oligonucleotide CDMO Market, Sub-Segmentation Of Oligonucleotides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antisense Oligonucleotides
- Sirna And Mrna Oligonucleotides
- Oligonucleotide Synthesis And Manufacturing Services
- 7. Peptide And Oligonucleotide CDMO Market Regional And Country Analysis
- 7.1. Global Peptide And Oligonucleotide CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Peptide And Oligonucleotide CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Peptide And Oligonucleotide CDMO Market
- 8.1. Asia-Pacific Peptide And Oligonucleotide CDMO Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Peptide And Oligonucleotide CDMO Market
- 9.1. China Peptide And Oligonucleotide CDMO Market Overview
- 9.2. China Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Peptide And Oligonucleotide CDMO Market
- 10.1. India Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Peptide And Oligonucleotide CDMO Market
- 11.1. Japan Peptide And Oligonucleotide CDMO Market Overview
- 11.2. Japan Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Peptide And Oligonucleotide CDMO Market
- 12.1. Australia Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Peptide And Oligonucleotide CDMO Market
- 13.1. Indonesia Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Peptide And Oligonucleotide CDMO Market
- 14.1. South Korea Peptide And Oligonucleotide CDMO Market Overview
- 14.2. South Korea Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Peptide And Oligonucleotide CDMO Market
- 15.1. Western Europe Peptide And Oligonucleotide CDMO Market Overview
- 15.2. Western Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Peptide And Oligonucleotide CDMO Market
- 16.1. UK Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Peptide And Oligonucleotide CDMO Market
- 17.1. Germany Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Peptide And Oligonucleotide CDMO Market
- 18.1. France Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Peptide And Oligonucleotide CDMO Market
- 19.1. Italy Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Peptide And Oligonucleotide CDMO Market
- 20.1. Spain Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Peptide And Oligonucleotide CDMO Market
- 21.1. Eastern Europe Peptide And Oligonucleotide CDMO Market Overview
- 21.2. Eastern Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Peptide And Oligonucleotide CDMO Market
- 22.1. Russia Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Peptide And Oligonucleotide CDMO Market
- 23.1. North America Peptide And Oligonucleotide CDMO Market Overview
- 23.2. North America Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Peptide And Oligonucleotide CDMO Market
- 24.1. USA Peptide And Oligonucleotide CDMO Market Overview
- 24.2. USA Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Peptide And Oligonucleotide CDMO Market
- 25.1. Canada Peptide And Oligonucleotide CDMO Market Overview
- 25.2. Canada Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Peptide And Oligonucleotide CDMO Market
- 26.1. South America Peptide And Oligonucleotide CDMO Market Overview
- 26.2. South America Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Peptide And Oligonucleotide CDMO Market
- 27.1. Brazil Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Peptide And Oligonucleotide CDMO Market
- 28.1. Middle East Peptide And Oligonucleotide CDMO Market Overview
- 28.2. Middle East Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Peptide And Oligonucleotide CDMO Market
- 29.1. Africa Peptide And Oligonucleotide CDMO Market Overview
- 29.2. Africa Peptide And Oligonucleotide CDMO Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Peptide And Oligonucleotide CDMO Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Peptide And Oligonucleotide CDMO Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Peptide And Oligonucleotide CDMO Market Competitive Landscape And Company Profiles
- 30.1. Peptide And Oligonucleotide CDMO Market Competitive Landscape
- 30.2. Peptide And Oligonucleotide CDMO Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Ajinomoto Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Lonza Group Ag Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Wuxi Apptec Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 31. Peptide And Oligonucleotide CDMO Market Other Major And Innovative Companies
- 31.1. Catalent Inc.
- 31.2. Piramal Pharma Ltd
- 31.3. Curia Global Inc.
- 31.4. Almac Group
- 31.5. Euroapi SA.
- 31.6. CordenPharma International
- 31.7. Bachem Holding AG
- 31.8. Genscript Biotech Corporation
- 31.9. PolyPeptide Group
- 31.10. Rentschler Biopharma SE
- 31.11. Ambiopharm Inc
- 31.12. ScinoPharm
- 31.13. Senn Chemicals AG
- 31.14. Aurigene Pharmaceutical Services
- 31.15. Creative Peptides
- 32. Global Peptide And Oligonucleotide CDMO Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Peptide And Oligonucleotide CDMO Market
- 34. Recent Developments In The Peptide And Oligonucleotide CDMO Market
- 35. Peptide And Oligonucleotide CDMO Market High Potential Countries, Segments and Strategies
- 35.1 Peptide And Oligonucleotide CDMO Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Peptide And Oligonucleotide CDMO Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Peptide And Oligonucleotide CDMO Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.